Inventor
Ruxandra Draghia-Akli
Inventor
Houston, TX, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides19%
C12NMicroorganisms or enzymes19%
A61NElectrotherapy5%
C07HSugars3%
A01KAnimal husbandry1%
PatentTitleYear
10,076,565Vaccines against multiple subtypes of influenza virus20189,592,285'Vaccines against multiple subtypes of influenza virus'20179,452,285'Electroporation devices and methods of using same for electroporation of cells in mammals'20169,156,891'Vaccines and methods for using the same'20159,156,890'HCV vaccines and methods for using the same'20158,962,818'Compositions comprising GHRH and GnRH and methods of using the same'20158,927,508'Antibody production elicited by a DNA vaccine delivered by electroporation'20158,921,536'HCV vaccines and methods for using the same'20148,829,174'HCV vaccines and methods for using the same'20148,563,302'Optimized high yield synthetic plasmids'20138,535,687'Smallpox DNA vaccine and the antigens therein that elicit an immune response'20138,481,504'Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications'20138,209,006'Constant current electroporation device and methods of use'20128,188,056'Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation'20128,178,504'Gene therapy expression of GHRH for increasing RBC count in subjects'20128,133,723'Vaccines against multiple subtypes of influenza virus'20128,058,253'Growth hormone releasing hormone treatment to decrease cholesterol levels'20117,846,720'Optimized high yield synthetic plasmids'20107,664,545'Electrode assembly for constant-current electroporation and use'20107,517,863'Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide'20097,361,642'Canine specific growth hormone releasing hormone'20087,338,656'Composition and method to alter lean body mass and bone properties in a subject'20087,316,925'Codon optimized synthetic plasmids'20087,250,405'Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy'20077,245,963'Electrode assembly for constant-current electroporation and use'20077,241,744'Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone'20076,423,693'Growth hormone releasing hormone expression system and methods of use, including use in animals'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2017Based in Houston, TX, US· patent location history
2008–2016Patents assigned to VGX PHARMACEUTICALS INC (14)· patent assignee history
2008Based in The Woodlands, TX, US· patent location history
2011–2017Patents assigned to DRAGHIA-AKLI RUXANDRA (14)· patent assignee history
2011–2016Patents assigned to KHAN AMIR S (5)· patent assignee history
2012–2018Patents assigned to UNIV PENNSYLVANIA (8)· patent assignee history
2012–2018Based in Brussels, BE· patent location history
2013–2015Patents assigned to INOVIO PHARMACEUTICALS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DRAGHIA-AKLI RUXANDRAself | 14 | 2011–2017 |
| VGX PHARMACEUTICALS INC | 14 | 2008–2016 |
| UNIV PENNSYLVANIA | 8 | 2012–2018 |
| INOVIO PHARMACEUTICALS INC | 5 | 2013–2015 |
| KHAN AMIR S | 5 | 2011–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Houston, Texas, US | 17 | 2002–2017 |
| Brussels, BE | 9 | 2012–2018 |
| The Woodlands, Texas, US | 1 | 2008 |